Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares (KNSA)
19.73
-0.15 (-0.75%)
Kiniksa Pharmaceuticals International Plc is a biotechnology company focused on developing innovative therapies for autoimmune and rare diseases
The company is engaged in advancing its pipeline of novel product candidates that target critical unmet medical needs, leveraging its expertise in immunology and inflammation. Kiniksa aims to bring effective treatments to patients through rigorous research and developmental strategies, seeking to improve the quality of life for individuals affected by challenging health conditions.
Frequently Asked Questions
Is Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares publicly traded?
Yes, Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares is publicly traded.
What exchange does Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares trade on?
Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares?
The ticker symbol for Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares is KNSA on the Nasdaq Stock Market
What is the current price of Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares?
The current price of Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares is 19.73
When was Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares last traded?
The last trade of Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares was at 1:33 pm EST on January 31st, 2025
What is the market capitalization of Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares?
The market capitalization of Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares is 1.42B
How many shares of Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares are outstanding?
Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares has 71.73M shares outstanding.